Open access
Aug 2026
Machine Learning-Guided Personalized Immunochemotherapy Strategies in Intrahepatic Cholangiocarcinoma.
BACKGROUND & AIMS Immunochemotherapy (IO-chemo) has become standard care for patients with unresectable intrahepatic cholangiocarcinoma (iCCA), but benefit of adding IO varies greatly among individuals. We sought to develop a system to identify patients most likely to benefit from this treatment based on individualized...
Jun-Hao Mei, Kai Zhang, Ying Zhang et al.
· JHEP Reports · 0 citations